Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)

on behalf of the COMPACT Investigators

doi:10.1186/s13023-021-01975-2

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)

on behalf of the COMPACT Investigators

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Following the publication of the original article [1] the authors informed us of an error in the second paragraph under ‘Study population’ of the ‘Results’ section.

Original language	English (US)
Article number	329
Journal	Orphanet Journal of Rare Diseases
Volume	16
Issue number	1
DOIs	https://doi.org/10.1186/s13023-021-01975-2
State	Published - Dec 2021

All Science Journal Classification (ASJC) codes

Genetics(clinical)
Pharmacology (medical)

Access to Document

10.1186/s13023-021-01975-2

Fingerprint

Dive into the research topics of 'Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)'. Together they form a unique fingerprint.

Cite this

on behalf of the COMPACT Investigators (2021). Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4). Orphanet Journal of Rare Diseases, 16(1), Article 329. https://doi.org/10.1186/s13023-021-01975-2

on behalf of the COMPACT Investigators. / Correction to : Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4). In: Orphanet Journal of Rare Diseases. 2021 ; Vol. 16, No. 1.

@article{13b260c83ea442229030899cfe67a354,

title = "Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)",

abstract = "Following the publication of the original article [1] the authors informed us of an error in the second paragraph under {\textquoteleft}Study population{\textquoteright} of the {\textquoteleft}Results{\textquoteright} section.",

author = "\{on behalf of the COMPACT Investigators\} and Lumry, \{William R.\} and Bruce Zuraw and Marco Cicardi and Timothy Craig and John Anderson and Aleena Banerji and Bernstein, \{Jonathan A.\} and Teresa Caballero and Henriette Farkas and Gower, \{Richard G.\} and Keith, \{Paul K.\} and Levy, \{Donald S.\} and Li, \{H. Henry\} and Markus Magerl and Michael Manning and Riedl, \{Marc A.\} and Lawo, \{John Philip\} and Subhransu Prusty and Thomas Machnig and Hilary Longhurst",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s13023-021-01975-2",

language = "English (US)",

volume = "16",

journal = "Orphanet Journal of Rare Diseases",

issn = "1750-1172",

publisher = "BioMed Central",

number = "1",

}

on behalf of the COMPACT Investigators 2021, 'Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)', Orphanet Journal of Rare Diseases, vol. 16, no. 1, 329. https://doi.org/10.1186/s13023-021-01975-2

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4). / on behalf of the COMPACT Investigators.
In: Orphanet Journal of Rare Diseases, Vol. 16, No. 1, 329, 12.2021.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4)

AU - on behalf of the COMPACT Investigators

AU - Lumry, William R.

AU - Zuraw, Bruce

AU - Cicardi, Marco

AU - Craig, Timothy

AU - Anderson, John

AU - Banerji, Aleena

AU - Bernstein, Jonathan A.

AU - Caballero, Teresa

AU - Farkas, Henriette

AU - Gower, Richard G.

AU - Keith, Paul K.

AU - Levy, Donald S.

AU - Li, H. Henry

AU - Magerl, Markus

AU - Manning, Michael

AU - Riedl, Marc A.

AU - Lawo, John Philip

AU - Prusty, Subhransu

AU - Machnig, Thomas

AU - Longhurst, Hilary

PY - 2021/12

Y1 - 2021/12

N2 - Following the publication of the original article [1] the authors informed us of an error in the second paragraph under ‘Study population’ of the ‘Results’ section.

AB - Following the publication of the original article [1] the authors informed us of an error in the second paragraph under ‘Study population’ of the ‘Results’ section.

UR - https://www.scopus.com/pages/publications/85111706621

UR - https://www.scopus.com/pages/publications/85111706621#tab=citedBy

U2 - 10.1186/s13023-021-01975-2

DO - 10.1186/s13023-021-01975-2

M3 - Comment/debate

C2 - 34321052

AN - SCOPUS:85111706621

SN - 1750-1172

VL - 16

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

IS - 1

M1 - 329

ER -

on behalf of the COMPACT Investigators. Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study (Orphanet Journal of Rare Diseases, (2021), 16, 1, (86), 10.1186/s13023-020-01658-4). Orphanet Journal of Rare Diseases. 2021 Dec;16(1):329. doi: 10.1186/s13023-021-01975-2

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this